Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells

被引：0
|
作者：
Prevatskaya, N [1 ]
Vanoverberghe, K [1 ]
Abeele, FV [1 ]
Mariot, P [1 ]
Roudbaraki, M [1 ]
Lepage, G [1 ]
Skryma, R [1 ]
机构：
[1] INSERM, EMI 0228, Villeneuve Dascq, France
来源：
BIOPHYSICAL JOURNAL | 2004年 / 86卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：457A / 457A
页数：1
相关论文
共 50 条
  • [1] Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells
    Vanoverberghe, K
    Vanden Abeele, F
    Mariot, P
    Lepage, G
    Roudbaraki, M
    Bonnal, JL
    Mauroy, B
    Shuba, Y
    Skryma, R
    Prevarskaya, N
    CELL DEATH AND DIFFERENTIATION, 2004, 11 (03): : 321 - 330
  • [2] Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells
    K Vanoverberghe
    F Vanden Abeele
    P Mariot
    G Lepage
    M Roudbaraki
    J L Bonnal
    B Mauroy
    Y Shuba
    R Skryma
    N Prevarskaya
    Cell Death & Differentiation, 2004, 11 : 321 - 330
  • [3] Ca2+ homeostasis in apoptotic resistance of prostate cancer cells
    Prevarskaya, N
    Skryma, R
    Shuba, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (04) : 1326 - 1335
  • [4] Somatostatin Imaging of Neuroendocrine-Differentiated Prostate Cancer
    Hope, Thomas A.
    Aggarwal, Rahul
    Simko, Jeff P.
    VanBrocklin, Henry F.
    Ryan, Charles J.
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (06) : 540 - 541
  • [5] Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer
    Mori, Hiroshi
    Nakajima, Kenichi
    Kadomoto, Suguru
    Mizokami, Atsushi
    Ikeda, Hiroko
    Wakabayashi, Hiroshi
    Kinuya, Seigo
    INTERNAL MEDICINE, 2018, 57 (21) : 3123 - 3128
  • [6] Insights into Ca2+ homeostasis of advanced prostate cancer cells
    Flourakis, Matthieu
    Prevarskaya, Natacha
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (06): : 1105 - 1109
  • [7] Endogenous H2S augments secretory functions via activation of Cav3.2 T-type Ca2+ channels in neuroendocrine-differentiated prostate cancer cells
    Fukami, Kazuki
    Kasamatsu, Ryuji
    Yoshida, Shigeru
    Sekiguchi, Fumiko
    Kawabata, Atsufumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 92P - 92P
  • [8] Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells
    Tawadros, Thomas
    Alonso, Florian
    Jichlinski, Patrice
    Clarke, Noel
    Calandra, Thierry
    Haefliger, Jacques-Antoine
    Roger, Thierry
    ENDOCRINE-RELATED CANCER, 2013, 20 (01) : 137 - 149
  • [9] PSMA and SSTR2 Dual-Targeting Theranostic Agents for Neuroendocrine-Differentiated Prostate Cancer (NEPC)
    Jin, Wenbin
    Yan, Li
    Li, Linlin
    Luo, Yang
    Qiao, Jinping
    Peng, Qiyu
    Zhu, Zhaohui
    Zhu, Lin
    Kung, Hank F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 1984 - 1993
  • [10] Regulation of Ca2+ signaling in prostate cancer cells
    Kilch, Tatiana
    Kappel, Sven
    Peinelt, Christine
    CHANNELS, 2016, 10 (03) : 170 - 171
12345